NO322048B1 - Lagringsstabil vannopplosning for infusjon inneholdende en trombininhibitor, fremgangsmate for fremstilling av slik vannopplosning og anvendelse derav. - Google Patents

Lagringsstabil vannopplosning for infusjon inneholdende en trombininhibitor, fremgangsmate for fremstilling av slik vannopplosning og anvendelse derav. Download PDF

Info

Publication number
NO322048B1
NO322048B1 NO19972065A NO972065A NO322048B1 NO 322048 B1 NO322048 B1 NO 322048B1 NO 19972065 A NO19972065 A NO 19972065A NO 972065 A NO972065 A NO 972065A NO 322048 B1 NO322048 B1 NO 322048B1
Authority
NO
Norway
Prior art keywords
hooc
solution
pic
nag
cha
Prior art date
Application number
NO19972065A
Other languages
English (en)
Norwegian (no)
Other versions
NO972065L (no
NO972065D0 (no
Inventor
Ulla Stjernfelt
Mats Sundgren
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO972065L publication Critical patent/NO972065L/no
Publication of NO972065D0 publication Critical patent/NO972065D0/no
Publication of NO322048B1 publication Critical patent/NO322048B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19972065A 1994-11-08 1997-05-05 Lagringsstabil vannopplosning for infusjon inneholdende en trombininhibitor, fremgangsmate for fremstilling av slik vannopplosning og anvendelse derav. NO322048B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9403831A SE504185C2 (sv) 1994-11-08 1994-11-08 Lagringsstabil vattenlösning för infusion av trombininhibitorer
PCT/SE1995/001228 WO1996014084A1 (en) 1994-11-08 1995-10-19 A storage stable water solution for infusion containing a thrombin inhibitor

Publications (3)

Publication Number Publication Date
NO972065L NO972065L (no) 1997-05-05
NO972065D0 NO972065D0 (no) 1997-05-05
NO322048B1 true NO322048B1 (no) 2006-08-07

Family

ID=20395892

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972065A NO322048B1 (no) 1994-11-08 1997-05-05 Lagringsstabil vannopplosning for infusjon inneholdende en trombininhibitor, fremgangsmate for fremstilling av slik vannopplosning og anvendelse derav.

Country Status (31)

Country Link
US (1) US5830865A (cs)
EP (1) EP0789585B1 (cs)
JP (1) JPH10508598A (cs)
KR (1) KR100416677B1 (cs)
CN (1) CN1090508C (cs)
AT (1) ATE205399T1 (cs)
AU (1) AU695719B2 (cs)
BR (1) BR9509634A (cs)
CA (1) CA2203396A1 (cs)
CZ (1) CZ287256B6 (cs)
DE (1) DE69522702T2 (cs)
DK (1) DK0789585T3 (cs)
EE (1) EE9700218A (cs)
ES (1) ES2163528T3 (cs)
FI (1) FI971949A7 (cs)
HU (1) HU217073B (cs)
IL (1) IL115879A (cs)
IS (1) IS4468A (cs)
MX (1) MX9703339A (cs)
MY (1) MY112593A (cs)
NO (1) NO322048B1 (cs)
NZ (1) NZ295492A (cs)
PL (1) PL320342A1 (cs)
PT (1) PT789585E (cs)
RU (1) RU2164803C2 (cs)
SE (1) SE504185C2 (cs)
SK (1) SK53597A3 (cs)
TR (1) TR199501391A2 (cs)
TW (1) TW407057B (cs)
WO (1) WO1996014084A1 (cs)
ZA (1) ZA959377B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984627B1 (en) * 1993-06-03 2006-01-10 Astrazeneca Ab Peptide derivatives
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
AR005245A1 (es) 1995-12-21 1999-04-28 Astrazeneca Ab Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion
SE9802974D0 (sv) 1998-09-03 1998-09-03 Astra Ab New crystalline forms
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
CN100513398C (zh) 2002-12-03 2009-07-15 Axys药物公司 作为因子viia抑制剂的2-(2-羟基联苯-3-基)-1h-苯并咪唑-5-甲脒衍生物
US7345093B2 (en) * 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
CA2781529C (en) 2009-09-23 2017-10-24 Indu Javeri Methods for the preparation of liposomes comprising docetaxel
MX2021008557A (es) * 2021-01-13 2021-11-17 Grupo Ion Biotech S A P I De C V Sistema de suministro de ionoforos quimicos de membrana celular sintetica que comprende composiciones de ligandos hexa-acuaticos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2096415C1 (ru) * 1991-09-30 1997-11-20 Дзе Дюпон Мерк Фармасьютикал Компани Циклические пептиды или их фармацевтически приемлемые соли, фармацевтическая композиция
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
US5466131A (en) * 1994-03-22 1995-11-14 Micropump Corporation Multiple-chamber gear pump with hydraulically connected chambers

Also Published As

Publication number Publication date
AU695719B2 (en) 1998-08-20
HUT77560A (hu) 1998-06-29
CZ129497A3 (cs) 1998-02-18
SK53597A3 (en) 1998-07-08
MY112593A (en) 2001-07-31
CN1162921A (zh) 1997-10-22
NO972065L (no) 1997-05-05
TW407057B (en) 2000-10-01
CZ287256B6 (en) 2000-10-11
DE69522702T2 (de) 2002-07-11
IS4468A (is) 1997-04-21
WO1996014084A1 (en) 1996-05-17
CA2203396A1 (en) 1996-05-17
SE504185C2 (sv) 1996-12-02
PL320342A1 (en) 1997-09-29
JPH10508598A (ja) 1998-08-25
SE9403831D0 (sv) 1994-11-08
AU3884695A (en) 1996-05-31
IL115879A0 (en) 1996-01-31
DE69522702D1 (de) 2001-10-18
SE9403831L (sv) 1996-05-09
DK0789585T3 (da) 2001-11-12
IL115879A (en) 2001-08-08
FI971949L (fi) 1997-05-07
PT789585E (pt) 2002-01-30
ZA959377B (en) 1996-05-08
FI971949A0 (fi) 1997-05-07
ATE205399T1 (de) 2001-09-15
US5830865A (en) 1998-11-03
KR970706844A (ko) 1997-12-01
NZ295492A (en) 1998-06-26
EP0789585A1 (en) 1997-08-20
ES2163528T3 (es) 2002-02-01
NO972065D0 (no) 1997-05-05
KR100416677B1 (ko) 2004-06-16
EP0789585B1 (en) 2001-09-12
HU217073B (hu) 1999-11-29
CN1090508C (zh) 2002-09-11
RU2164803C2 (ru) 2001-04-10
BR9509634A (pt) 1998-01-06
MX9703339A (es) 1997-07-31
FI971949A7 (fi) 1997-05-07
EE9700218A (et) 1998-02-16
TR199501391A2 (tr) 1996-06-21

Similar Documents

Publication Publication Date Title
US7985757B2 (en) Argatroban formulation
EP2586459B1 (en) Vegf antagonist formulations
US9283197B1 (en) More potent and less toxic formulations of epinephrine and methods of medical use
ES2223549T3 (es) Formulacion que contiene moxifloxacino y sal comun.
US10039728B1 (en) More potent and less toxic formulations of epinephrine and methods of medical use
US10980757B2 (en) Ready-to-use tranexamic acid intravenous solution
BR112016019804B1 (pt) Processo para produção de uma solução estável, injetável, de baixa concentração de noradrenalina
AU695719B2 (en) A storage stable water solution for infusion containing a thrombin inhibitor
US20220151956A1 (en) More potent and less toxic formulations of epinephrine and methods of medical use
US10004700B1 (en) More potent and less toxic formulations of epinephrine and methods of medical use
CN108324683A (zh) 一种稳定的大输液依达拉奉注射液及其制备工艺
NO123024B (cs)
Stendal et al. Drug stability and pyridine generation in ceftazidime injection
US20240197621A1 (en) Buffered Lidocaine Injectable Formulations and Methods for Making Same
Mitrano et al. Chemical and visual stability of amphotericin B in 5% dextrose injection stored at 4 degrees C for 35 days
JPH1149698A (ja) 安定性を向上させたラクトフェリンの水性製剤
Carpenter et al. Stability of omeprazole sodium and pantoprazole sodium diluted for intravenous infusion
De Luca et al. 3PC-043 Intravitreal preparation of liposomal b amphotericin: from formulation study to preparation
RU2732407C1 (ru) Фармацевтическая композиция, содержащая палоносетрон в качестве активного ингредиента
Horak et al. TCH-023 Liquid Oral Formulations of Propranolol Hydrochloride For the Treatment of Infantile Haemangiomas
CN116251057A (zh) 一种硝酸异山梨酯注射液及其制备方法
CN111372573A (zh) 多离子输注溶液
NO144057B (no) Fremgangsmaate for aa minske vannbehovet og eliminere utslipp av forurensninger ved behandling av halm med alkali i vannopploesning for aa oeke dens forverdi